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Abstract. Although on-animal topical treatment with compounds such as imidaclo-
prid has revolutionized the control of the cat flea, Ctenocephalides felis (Bouche´)
(Siphonaptera: Pulicidae), the development of insecticide resistance is a continuing
threat. As part of a highly co-ordinated and unprecedented resistance monitoring pro-
gramme for C. felis, 1437 flea isolates were collected by veterinary clinics in Australia,
Germany, France, the U.K. and 29 states in the U.S.A. from 2002 to 2009. About
65% of the collections were made from June to October each year and 71% of the
collections were from cats. Collections of flea eggs were sent to one of five different
laboratories, where they were tested with a diagnostic dose of imidacloprid (3 p.p.m.)
applied to larval flea-rearing medium. Of the 1437 collections received, 1064 con-
tained adequate numbers of eggs for testing. Of these isolates, untreated eggs failed
to hatch in 22.7% and were not considered valid bioassays. Survival rates >5% and
development of adult fleas (a threshold for further testing) occurred in only 22 iso-
lates. They were re-tested with the same diagnostic dose and none produced >5% adult
emergence. Complete dose–response bioassays were performed on three of the iso-
lates that had triggered a second test and produced slopes, intercepts and LC50 values
similar to those for existing susceptible laboratory strains. Results confirmed sustained
susceptibility of C. felis to imidacloprid, despite its widespread use for over a decade.
Key words. Ctenocephalides felis, cat flea, diagnostic dose, imidacloprid, insecticide
resistance, resistance monitoring.
Introduction
The introduction of insecticides for veterinary use, such as
dinotefuran, fipronil, imidacloprid, lufenuron, metaflumizone,
nitenpyram, pyriprole, selamectin and spinosad, has revolution-
ized the control of the cat flea Ctenocephalides felis (Bouche´)
Correspondence: Michael K. Rust, Department of Entomology, University of California Riverside, Riverside, CA 92521-0314, U.S.A.
Tel.: +1 951 827 5327; Fax: +1 951 827 3086; E-mail: michael.rust@ucr.edu
on cats and dogs (Rust, 2005, 2010; Blagburn & Dryden,
2009). Previous strategies employing carbamates, organophos-
phates, pyrethroids and pyrethrins led to documented cases
of insecticide resistance in flea populations (Bossard et al.,
1998, 2002). Biotic factors, such as the flea’s rapid lifecycle
(18–20 days), the high fecundity of female fleas (up to
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400 eggs per female during her lifetime) and the limited
movement of adult fleas, and operational factors, such as the
persistence of chemical treatments and repetitive applications,
are known to contribute to the rapid development of resistance
(Georghiou, 1983; Denholm & Rowland, 1992). Although on-
animal topical treatments such as imidacloprid and fipronil
have been widely used for a decade, there have been only a
few sporadic and undocumented reports of the development of
perceived product failures. Bardt & Schein (1996) reported that
a field-collected isolate (Cottontail) was resistant to lufenuron
and had reduced susceptibility to fipronil. Payne et al. (2001)
reported reduced activity of fipronil to another flea isolate (R6)
after residues had aged for 3 weeks. Molecular analyses of
several flea isolates showed that alleles conferring cyclodiene
resistance and potential cross-resistance to fipronil (Rdl ) (Bass
et al., 2004a; Daborn et al., 2004) and knock-down resistance
(kdr) to pyrethroids (Bass et al., 2004b) occur in C. felis. The
Cottontail isolate possessed the Rdl allele (Bass et al., 2004a),
suggesting a possible link between this allele and insensitiv-
ity to fipronil. By contrast, Brunet et al. (2009) reported that
six isolates of C. felis homozygous for Rdl, tested 3–6 years
before the Rdl diagnosis, were fully susceptible to topical
applications of fipronil. The prevalence of Rdl in C. felis has
not been investigated systematically and its impact on fipronil
treatments is still unresolved. The survival of some individ-
uals of a laboratory strain of C. felis when exposed to cats
28 days after treatment with fipronil or imidacloprid raised
concerns over resistance to these compounds (Dryden et al.,
2005). However, there was no evidence of the strain showing
resistance in larval bioassays with imidacloprid [Rust et al.,
2005 (in which the strain is referred to as KSU)]. Repeated
exposure of KS1 for nine generations to larval medium treated
with an LC35 (35% lethal concentration) dose of imidacloprid
failed to cause any shift in response (M. K. Rust, unpublished
data, 2003).
In the crop protection sector, cases of resistance to
neonicotinoid compounds such as imidacloprid have been
shown to compromise control of some insect pests (Nauen
& Denholm, 2005; Karunker et al., 2008). There have been no
confirmed cases of resistance to imidacloprid in the veterinary
sector, but careful vigilance is required. For this reason, the
susceptibility of C. felis to imidacloprid has been monitored
extensively in Europe and the U.S.A., and is now being
monitored in Australia, in a highly co-ordinated programme
in which flea samples are collected in veterinary clinics, sent
to one of five participating research laboratories, and tested
for their response to a diagnostic concentration (3 p.p.m.) of
imidacloprid using a larval diet incorporation bioassay (Rust
et al., 2002, 2005; Blagburn et al., 2006). The advantage of
this approach is that larvae hatching from eggs collected in the
field can be tested without the need to rear isolates to adulthood
in the laboratory. Isolates that are obviously fully susceptible to
imidacloprid can be discarded and only potentially interesting
isolates need to be propagated on host animals for further
examination using full dose–response bioassays.
The current study reports results of this monitoring pro-
gramme obtained between 2002 and 2009 for fleas collected
from veterinary clinics in Australia, Germany, France, the
U.K. and the U.S.A. The work exemplifies the challenges and
benefits of large-scale resistance monitoring and demonstrates
the continuing sensitivity of C. felis to imidacloprid.
Materials and methods
Collection of field samples
Veterinary clinics throughout the U.S.A. (n = 131), the U.K.
(n = 36), France (n = 8), Australia (n = 4) and Germany
(n = 16) were recruited to collect and send flea eggs to one
of six designated research laboratories in California, Kansas
and Alabama (U.S.A.), London (U.K.), Brisbane (Australia)
and Monheim (Germany). Each clinic was provided with a
kit and a detailed protocol for collection and shipment. An
accompanying questionnaire requested information concerning
each cat and dog, treatment history and details of other
pets in the household (Rust et al., 2005; Blagburn et al.,
2006).
To collect flea eggs, blank newsprint or cardboard was
placed on a table or floor. A cage with an open-grate floor
and an animal infested with fleas were placed over the paper.
Food, water and litter pans were provided as needed. After
4–24 h, the animal was gently brushed or combed to dislodge
flea eggs. The debris and eggs were brushed to the centre of
the paper and poured through a sieve and funnel into a glass.
The tube was covered with filter paper and sealed with white
tape or parafilm.
In the U.S.A. and Australia, tubes were placed in a styrofoam
cooler with insulation adequate to protect them and sent
overnight to one of the laboratories. In Germany, France and
the U.K., where climatic conditions were often less extreme
and transportation distances much shorter, tubes were wrapped
in bubblewrap and posted in a special delivery envelope (Rust
et al., 2005).
Diagnostic dose bioassays
Each laboratory determined the activity of imidacloprid
against the field-collected cat flea isolates according to the
protocol reported by Rust et al. (2005). For the initial phase of
testing, larval rearing medium was treated with technical grade
imidacloprid in acetone to provide a 3-p.p.m. concentration
(w/w) of imidacloprid. This concentration had been determined
previously to be optimal for disclosing potential cases of
resistance to imidacloprid (Rust et al., 2005). Treated medium
was placed into glass Petri dishes (5.0 cm diameter, 1.5 cm
depth) and 20 eggs were placed into each Petri dish using a
fine camel hair brush (size 0000).
Depending on sample size, up to six replicates were set
up using treated medium and up to three replicates using
untreated medium were run as controls. The glass Petri dishes
and flea eggs were placed in incubators maintained at 26 ±
2 ◦C, 80–85% relative humidity (RH) and an LD 12 : 12 h
photoperiod. In addition, 20 eggs of standard reference strains
of C. felis maintained by each laboratory were placed on
untreated medium as an internal check on environmental
conditions affecting egg hatch.
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Twelve days after the eggs had been added to the medium,
pupae and larvae were counted and returned to the incubator.
The number of adults that emerged was counted on day 28 in
both the treated and untreated replicates.
Second diagnostic dose bioassays
If >5% of the eggs exposed to the 3-p.p.m. concentration of
imidacloprid in the first diagnostic dose bioassay emerged as
adults, the survivors of the untreated controls were collected
for rearing. In the case of the participating laboratory at
Auburn, AL, these were sent overnight to the laboratory at
the University of California Riverside, Riverside, CA. The
adult fleas were placed on cats and the isolate was propagated
using standard rearing procedures (Rust et al., 2002). Cat flea
eggs were collected from trays underneath cats supporting each
isolate. The eggs and debris were passed through a series of
four sieves (10-, 16-, 20- and 60-mesh) and eggs were retained
on the 60-mesh screen.
The larval bioassay was repeated with three replicates of
20 flea eggs in medium treated with 3 p.p.m. imidacloprid.
Twelve days after the eggs had been added to the Petri dishes,
pupae and larvae were counted and returned to the incubator.
The number of adults that emerged was counted on day 28 in
both the treated and untreated medium.
Full dose–response bioassays
This phase of the monitoring programme applied only to
isolates whose survival exceeded 5% when exposed to the
3-p.p.m. dose in both the initial and second diagnostic dose
bioassays. However, a small number of field isolates that
exceeded the threshold in the initial diagnostic dose screen
were also used to establish dose–response relationships for
comparison with susceptible reference strains. Adults of these
isolates emerging from untreated controls were collected and
propagated on cats using standard rearing procedures (Rust
et al., 2002). When sufficient numbers of eggs were collected,
full dose–response bioassays were initiated.
Larval rearing medium was treated with technical grade
imidacloprid to provide the following concentrations in p.p.m.:
30, 15, 10, 5, 3, 1, 0.5, 0.1 and 0.05. Treated medium was
placed into glass Petri dishes (5.0 cm diameter, 1.5 cm depth)
and eggs added as before. To determine the number of flea
eggs that hatched, eggs were glued to the upper inner surface
of the Petri dish. A thin streak of glue (UHUStic; Saunders
Manufacturing Co., Winthrop, ME, U.S.A.) was applied to the
glass with a moistened paint brush. Eggs were carefully placed
onto the Petri dish lid and rolled onto the tacky surface with a
fine camel hair brush (size 0000). Once the glue dried, the eggs
remained attached to the Petri dish lid. As the eggs hatched, the
larvae fell into the medium, preventing larvae from consuming
flea eggs and providing an accurate count of larvae entering
the test. The design also minimized the impact of cannibalism
on larval mortality. The glass Petri dishes and flea eggs were
placed in incubators and maintained at 26 ± 2 ◦C and 80%
RH. Larvae and pupae were counted on day 12 as before,
returned to incubators, and the number of adults that emerged
or developed in the cocoons was counted on day 28.
Baseline data for standard susceptible laboratory strains
maintained at four of the laboratories were compared with
data for field-collected isolates. The adult emergence data were
analysed by probit analysis (Robertson & Preisler, 1992) using
polo Version 1.0 (LeOra Software, Menlo Park, CA, U.S.A.).
This study was conducted according to the ‘Guide for the
Care and Use of Laboratory Animals’ promulgated by the
Committee on Care and Use of Laboratory Animals of the
Institute of Laboratory Animal Resources, National Research
Council, 1996 and protocols adopted by each institution.
Results
A total of 1437 samples of C. felis were collected from
clinics and sent to testing laboratories between 2002 and 2009
(Table 1). About 71% of the samples were collected from cats
and 28% from dogs (Table 1). This probably reflects the fact
that cats are much easier to hold overnight in cages. Between
6% and 9% of the samples collected from 2003 to 2007 came
from animals with a previous history of imidacloprid use. In
2008 and 2009, these proportions increased to 13% and 16%,
respectively.
Diagnostic dose bioassays
Of the 1437 samples received, 822 (57%) yielded data
that contributed to the monitoring programme (Table 2). This
discrepancy arose for two reasons. Firstly, numbers of eggs in
a percentage of samples received each year were insufficient to
conduct bioassays, highlighting a difficulty in training staff in
clinics to assess the severity of flea infestation and to adhere
to collection protocols. However, this problem decreased in
importance over successive years. Secondly, a proportion of
samples used for the bioassays showed no egg hatch or an
inadequate hatch rate, even in Petri dishes containing untreated
larval medium. This problem appears to have increased over
time, possibly as a result of prior contamination from treatment
of animals with insect growth regulators (IGRs). In 2002, 77%
of the eggs received hatched; this declined to 48% in 2009.
Adults emerging from untreated larval medium were checked
for stout bristles on the dorsal margin of the hind tibia, which
Table 1. Flea egg samples collected from cats and dogs during 2002
to 2009.
Samples collected and shipped, n
Host 2002 2003 2004 2005 2006 2007 2008 2009 Total
Cats 112 110 194 163 94 41 126 184 1024
Dogs 25 38 51 33 23 19 77 135 401
Other* 0 2 2 2 0 1 3 2 12
Total 137 150 247 198 117 61 206 321 1437
*Host not specified.
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Table 2. Summary of the diagnostic dose bioassays with imidacloprid
conducted between 2002 and 2009.
Year
Samples
received,
n
Valid
bioassays,
n
Eggs
tested at
3 p.p.m.,
n
Adults
emerging,
n
Percentage
emergence
2002 137 106 9714 22 0.2%
2003 150 106 9657 50 0.5%
2004 247 171 16 336 30 0.2%
2005 198 130 13 342 28 0.2%
2006 117 51 6480 105 1.6%
2007 61 34 2660 1 <0.1%
2008 206 70 5620 68 1.2%
2009 321 154 8680 68 0.8%
Total 1437 822 72 489 372 0.5%
are characteristic of the closely related Ctenocephalides canis
(Hopkins & Rothschild, 1953), but none were found.
Out of a total of 72 489 eggs in the 822 samples tested
with 3 p.p.m. imidacloprid, 372 individuals (0.5%) survived
to adulthood from 22 different isolates (Table 2). There was
no evidence of an increasing trend in survival from year to
year. Annual survival rates varied from a minimum of <0.1%
in 2007 to a maximum of 1.6% in 2006. Although numbers
of survivors were too low to allow detailed statistical analysis,
visual inspection of the data suggests no consistent association
of survival with the testing laboratory, host species, season of
collection or prior treatment with insecticide.
The diagnostic dose test was repeated for isolates that
exceeded the 5% survival threshold when sufficient eggs were
available for that particular isolate. In the second diagnostic
dose test, none of these isolates exceeded the 5% survival
threshold, implying that survival was a chance effect rather
than indicating a systematic shift in susceptibility.
Full dose–response bioassays
The full dose exposure test was conducted on three of
the field isolates, AUS 1, USA 1 and USA 2 that allowed
for >5% survival of adult fleas in the first diagnostic dose
screen, although these proved fully susceptible in the second
screen (Table 3). These were compared with three reference
susceptible strains, AUB, KS1 and UCR, that had been reared
in one or more of the testing laboratories for ≥10 years
without exposure to insecticides. None of the LC50 or LC95
values for the field isolates lay outside the range of values for
the laboratory strains (based on the lack of overlap of 95%
confidence intervals).
Discussion
Field isolates of C. felis were obtained from clinics in Europe,
Australia and the U.S.A., corroborating previous findings on
the year-round occurrence of this species (Lyon, 1915; Osbrink
& Rust, 1985; Clark, 1999). However, more isolates were
received in the summer (n = 518) and autumn (n = 575) than
either the spring (n = 184) or winter (n = 144). Clark (1999)
reported that about 25% of adult female fleas collected from
cats and dogs in the U.K. during the winter had mature oocytes;
our experience suggests that, although the number of flea eggs
during winter months is comparatively low, their presence
represents an ongoing infestation and the nucleus for the large
increase in flea populations in June and July, when indoor
conditions are favourable for larval development. This supports
the use of topical treatments through the winter and before
the primary flea season, although the concept of preventive
applications of flea products during the winter and early spring
warrants some additional research.
Of the 822 valid diagnostic dose bioassays conducted
between 2002 and 2009, only 22 isolates enabled >5% flea
survival when exposed to 3 p.p.m. imidacloprid. This dose had
previously been established as the optimal dose for diagnosing
possible cases of reduced susceptibility on the basis of ring-
testing of several field isolates and laboratory strains (Rust
et al., 2005). The second diagnostic dose assay was intended
to verify the results of the first and none of the isolates that
triggered a survival rate >5% in the first test gave survivors in
the second. Thus, the few ‘positive’ results from the monitoring
programme so far do not appear to have reflected the presence
of individuals resistant to imidacloprid. This was supported
by full dose–response bioassays on a limited number of these
isolates, none of which exhibited dose–response relationships
that differed significantly from those of reference laboratory
susceptible strains. The emergence of some adults must,
therefore, represent chance survival or extremes in the normal
range of susceptibility rather than physiological resistance.
The diagnostic dose used in the programme effectively
eliminated 99% of the isolates from being maintained on hosts
Table 3. Dose–response bioassays of three field isolates and laboratory strains of cat fleas to imidacloprid.
Isolates/strains∗
(testing laboratory) n Slope ± SE LC50 (95% CI) LC95 (95% CI)
AUS 1 (AUS) 268 3.8 ± 0.80 0.48 (0.322–0.611) 1.29 (0.577–2.240)
USA 1 (UCR) 245 2.9 ± 0.49 0.18 (0.071–0.291) 0.67 (0.415–1.981)
USA 2 (AUB) 206 4.7 ± 1.39 0.48 (0.225–0.658) 1.06 (0.749–3.501)
UCR (UCR) 505 6.5 ± 1.16 1.25 (1.038–1.427) 2.24 (1.838–3.756)
KS1 (KSU) 1208 4.3 ± 0.62 0.73 (0.566–0.851) 1.75 (1.405–2.638)
AUB (AUB) 394 5.5 ± 1.06 0.48 (0.395–0.564) 0.97 (0.802–1.383)
∗AUB, Auburn University; AUS, University of Queensland; KSU, Kansas State University; UCR, University of California Riverside.
SE, standard error; LC50, 50% lethal concentration; 95% CI, 95% confidence interval.
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and tested further, resulting in the saving of considerable time
and other resources.
In recent years, the number of bioassays showing little or
no egg hatch in untreated controls has increased dramatically.
Weather conditions, especially in hot dry summer months,
can affect the viability of flea eggs collected from the pans.
However, the eggs were not dented as they are when they
desiccate. If weather conditions were a factor, then we would
have expected them to represent a relatively consistent factor
from year to year in the late summer. A more likely explanation
is that an increasing number of veterinarians and pet owners are
using combination products that include an IGR. In 2004, three
pet owners reported the use of products such as Frontline
Plus (Merial Ltd, Duluth, GA, U.S.A.) [9.8% fipronil and
8.8% (S)-methoprene]. In 2009, this had increased to eight
pet owners. The IGR fenoxycarb affects early blastoderm
formation, blastkinesis and advanced larval development up
to hatching (Marchiondo et al., 1990). Use of methoprene
on cats can greatly reduce the hatching success of eggs of
C. felis for up to 50 days after treatment (Olsen, 1985). The
IGR pyriproxyfen affects yolk deposition, causing the egg
to collapse after being laid (Palma et al., 1993). However,
eggs from methoprene-treated fleas show no visual signs and
remain turgid, but fail to hatch or the larvae die quickly
after hatching (Palma et al., 1993). Combination treatments
of fipronil and methoprene provided >90% ovicidal activity
for ≥8 weeks (Young et al., 2004). In 2009, we investigated
several cases in which no control eggs hatched by retaining
flea debris that accompanied the egg collection and adding
dried beef blood and flea eggs from our laboratory colonies.
None of the laboratory eggs hatched, suggesting that the debris
was possibly contaminated with an IGR. Further studies are
warranted to determine why the eggs in an increasing number
of isolates have not been hatching. This may have an important
impact on future resistance monitoring of eggs and larval
stages.
Insecticide resistance monitoring is a key step in develop-
ing a comprehensive strategy to delay the development of
resistance in C. felis to insecticides and to conserve impor-
tant chemistries for the future. In addition to demonstrating an
ongoing lack of insecticide resistance of C. felis to imidaclo-
prid, the work described here demonstrates that the consider-
able logistical challenges involved in monitoring for shifts in
susceptibility on an international scale and for a long period
can be met through careful standardization and co-ordination of
collecting and testing protocols. Similar programmes could be
adopted for other active ingredients provided that satisfactory
bioassays specifically designed for the relevant active ingredi-
ent are developed and validated.
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